Notably, the supplement of GM-CSF and TSLP completely rescue the proliferation and invasion of 4T1 or MDA-MB-231 cells (Figure 4A–C and Supplementary Figure S2A–C), suggesting that arctigenin inhibits breast cancer cell proliferation and invasion via GM-CSF and TSLP. Here, CSF2 is linked to breast cancer.